9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene

C114H68N12 — CID 160774939

IUPAC9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene
SMILESc1cc(-c2ccncc2)nc(-n2c3cccnc3c3c4ccc5cccc6ccc(cc32)c4c65)c1.c1ccc(-n2c(-c3ccc(-c4ccc5ccc6c7c(ccc4c57)cc4c6c5ncccc5n4-c4ccccc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c3cccnc3c3c4ccc5ccc(-c6cccc(-c7ccncc7)n6)c6ccc(cc32)c4c56)cc1
InChIInChI=1S/C46H28N4.C37H22N4.C31H18N4/c1-3-10-33(11-4-1)49-40-16-9-27-47-45(40)44-37-26-22-30-21-24-35(36-25-23-32(28-41(44)49)43(37)42(30)36)29-17-19-31(20-18-29)46-48-38-14-7-8-15-39(38)50(46)34-12-5-2-6-13-34;1-2-6-26(7-3-1)41-32-10-5-19-39-37(32)36-29-16-12-24-11-14-27(28-15-13-25(22-33(36)41)35(29)34(24)28)31-9-4-8-30(40-31)23-17-20-38-21-18-23;1-4-20-9-10-22-18-26-30(23-12-11-21(5-1)28(20)29(22)23)31-25(7-3-15-33-31)35(26)27-8-2-6-24(34-27)19-13-16-32-17-14-19/h1-28H;1-22H;1-18H
InChIKeyRZUYZRCKDWNNRB-UHFFFAOYSA-N
MW1605.88 g/mol
LogP28.48
Rot. Bonds9

About 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene

9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene (PubChem CID 160774939) has the molecular formula C114H68N12 and a molecular weight of 1605.88 g/mol. Its IUPAC name is 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene.

Molecular Properties

Compound Name9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene
PubChem CID160774939
Molecular FormulaC114H68N12
Molecular Weight1605.88 g/mol
Exact Mass1604.57
IUPAC Name9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene
SMILESc1cc(-c2ccncc2)nc(-n2c3cccnc3c3c4ccc5cccc6ccc(cc32)c4c65)c1.c1ccc(-n2c(-c3ccc(-c4ccc5ccc6c7c(ccc4c57)cc4c6c5ncccc5n4-c4ccccc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c3cccnc3c3c4ccc5ccc(-c6cccc(-c7ccncc7)n6)c6ccc(cc32)c4c56)cc1
InChIInChI=1S/C46H28N4.C37H22N4.C31H18N4/c1-3-10-33(11-4-1)49-40-16-9-27-47-45(40)44-37-26-22-30-21-24-35(36-25-23-32(28-41(44)49)43(37)42(30)36)29-17-19-31(20-18-29)46-48-38-14-7-8-15-39(38)50(46)34-12-5-2-6-13-34;1-2-6-26(7-3-1)41-32-10-5-19-39-37(32)36-29-16-12-24-11-14-27(28-15-13-25(22-33(36)41)35(29)34(24)28)31-9-4-8-30(40-31)23-17-20-38-21-18-23;1-4-20-9-10-22-18-26-30(23-12-11-21(5-1)28(20)29(22)23)31-25(7-3-15-33-31)35(26)27-8-2-6-24(34-27)19-13-16-32-17-14-19/h1-28H;1-22H;1-18H
InChIKeyRZUYZRCKDWNNRB-UHFFFAOYSA-N
XLogP28.48
TPSA122.84 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms126
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001605.88
LogP ≤ 528.48
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene?
The IUPAC name of 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene (CID 160774939) is 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene.
What is the SMILES notation for 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene?
The canonical SMILES for 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene is c1cc(-c2ccncc2)nc(-n2c3cccnc3c3c4ccc5cccc6ccc(cc32)c4c65)c1.c1ccc(-n2c(-c3ccc(-c4ccc5ccc6c7c(ccc4c57)cc4c6c5ncccc5n4-c4ccccc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c3cccnc3c3c4ccc5ccc(-c6cccc(-c7ccncc7)n6)c6ccc(cc32)c4c56)cc1.
What is the InChIKey of 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene?
The InChIKey is RZUYZRCKDWNNRB-UHFFFAOYSA-N. The full InChI is InChI=1S/C46H28N4.C37H22N4.C31H18N4/c1-3-10-33(11-4-1)49-40-16-9-27-47-45(40)44-37-26-22-30-21-24-35(36-25-23-32(28-41(44)49)43(37)42(30)36)29-17-19-31(20-18-29)46-48-38-14-7-8-15-39(38)50(46)34-12-5-2-6-13-34;1-2-6-26(7-3-1)41-32-10-5-19-39-37(32)36-29-16-12-24-11-14-27(28-15-13-25(22-33(36)41)35(29)34(24)28)31-9-4-8-30(40-31)23-17-20-38-21-18-23;1-4-20-9-10-22-18-26-30(23-12-11-21(5-1)28(20)29(22)23)31-25(7-3-15-33-31)35(26)27-8-2-6-24(34-27)19-13-16-32-17-14-19/h1-28H;1-22H;1-18H.
What are the key properties of 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene?
9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene has a molecular weight of 1605.88 g/mol, XLogP of 28.48, 9 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 9-phenyl-16-[4-(1-phenylbenzimidazol-2-yl)phenyl]-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-phenyl-16-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-(6-pyridin-4-yl-2-pyridinyl)-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15(23),16,18,20-undecaene is sourced from PubChem (CID 160774939), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).